Pain and Inflammation

The only randomized cannabis study in migraine attacks showed no superiority of CBD over placebo. Check what was studied, what interactions exist, and when to see a doctor.

Cannabinoids in neuropathic pain without marketing: Cochrane review, NeuPSIG guidelines, Hamburg study, drug interactions, and Polish Rpw prescription rules.

Cochrane, IASP, and meta-analyses on cannabinoids in chronic pain: what has been proven, what hasn’t, and why benefits may not outweigh harms.

The only randomized study on migraine attacks showed that CBD alone did not perform better than placebo. We gather data, interactions with medications, and alarm symptoms.